CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I/II Study of the Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Advanced Pancreas Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04327986
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:39.265840+00:00
Published At: 2022-05-18T00:00:00+00:00
Record Updated At: 2022-05-18
Results Posted At: 2022-05-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Histologically or Cytologically Confirmed Pancreatic Cancer", "Unresectable or Borderline Resectable Pancreatic Cancer", "Pancreatic Neoplasms", "Pancreatic Cancer", "Metastatic Pancreatic Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-05-18"
protocolSection.identificationModule.nctId: "NCT04327986"
protocolSection.identificationModule.officialTitle: "A Phase I/II Study of the Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Advanced Pancreas Cancer"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2022-05-18"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.